SERPINA1 and chronic obstructive pulmonary disease: Determining whether the increased COPD risk in PI MZ heterozygotes is due to low levels of AAT (loss of function) or due to the harmful effects of Z-AAT (toxic gain of function) could have therapeutic implications.